List of SBIR/STTR awards granted to Intra-Cellular Therapies | 6 results

Name	Description	SBIR/STTR Award Recipient	Government Agency	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase I Award, November 2005	A SBIR Phase I contract was awarded to Intra-Cellular Therapies in November, 2005 for $119,438.0 USD from the U.S. Department of Defense.	Intra-Cellular Therapies	U.S. Department of Defense	SBIR	W81XWH-06-C-0013	Phase I	119,438	November 10, 2005	sbir.gov/content/development-pre-and-post-exposure-neural-protectants-against-organophosphorus-op-compounds-0
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase II Award, August 2006	A SBIR Phase II contract was awarded to Intra-Cellular Therapies in August, 2006 for $729,913.0 USD from the U.S. Department of Defense.	Intra-Cellular Therapies	U.S. Department of Defense	SBIR	W81XWH-06-C-0013	Phase II	729,913	August 25, 2006	sbir.gov/content/development-novel-glutamate-antagonists-neural-protectants-against-organophosphorus-op-com-0
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase I Award, June 2016	A SBIR Phase I contract was awarded to Intra-Cellular Therapies in June, 2016 for $348,094.0 USD from the U.S. Department of Health & Human Services.	Intra-Cellular Therapies		SBIR	1R43MH108209-01A1	Phase I	348,094	June 1, 2016	sbir.gov/node/1164269
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Intra-Cellular Therapies for $349,610.0 USD from the U.S. Department of Health & Human Services.	Intra-Cellular Therapies		SBIR	1R43MH102849-01	Phase I	349,610		sbir.gov/node/706237
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Intra-Cellular Therapies for $249,377.0 USD from the U.S. Department of Health & Human Services.	Intra-Cellular Therapies		SBIR	1R43MH067488-01	Phase I	249,377		sbir.gov/content/phosphoproteome-analysis-antidepressant-drugs-0
‌ INTRA-CELLULAR THERAPIES, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Intra-Cellular Therapies for $2,897,070.0 USD from the U.S. Department of Health & Human Services.	Intra-Cellular Therapies		SBIR	2R44MH067488-05	Phase II	2,897,070		sbir.gov/content/novel-pde-inhibitors-treatment-cognitive-dysfunction-schizophrenia-0